Menu
18/06/2012
IPHA Say HSE Not Funding New Medicines
The organisation representing the pharmaceutical industry has claimed that patients are not getting access to new medicines.
The Irish Pharmaceutical Healthcare Association (IPHA) also claims that the HSE is not funding medicines that have been independently deemed as cost-effective.
David Gallagher, President of the IPHA, said that over the last six to eight months, effectively no new innovative medicines have been added to the drug reimbursement scheme.
He said that there were a good eight or ten medicines that have gone through the licensing process and a health technology assessment that have been proven to be cost effective.
Mr Gallagher said, "that ordinarily there would be reimbursement, but since September they haven't been added to the reimbursement scheme."
IPHA said patients are not getting access to new medicines for multiple sclerosis, heart conditions, bipolar disorder and Hepatitis C, while there are restrictions on others.
The HSE has set a target of €112m in drug savings this year, adding that it negotiates directly with drug companies on price to try and find a sustainable way to make new drugs available for public use.
An agreement between the IPHA and the Department of Health on the provision of medicines lapsed at the end of February and discussions are under way on a new agreement.
(H)
The Irish Pharmaceutical Healthcare Association (IPHA) also claims that the HSE is not funding medicines that have been independently deemed as cost-effective.
David Gallagher, President of the IPHA, said that over the last six to eight months, effectively no new innovative medicines have been added to the drug reimbursement scheme.
He said that there were a good eight or ten medicines that have gone through the licensing process and a health technology assessment that have been proven to be cost effective.
Mr Gallagher said, "that ordinarily there would be reimbursement, but since September they haven't been added to the reimbursement scheme."
IPHA said patients are not getting access to new medicines for multiple sclerosis, heart conditions, bipolar disorder and Hepatitis C, while there are restrictions on others.
The HSE has set a target of €112m in drug savings this year, adding that it negotiates directly with drug companies on price to try and find a sustainable way to make new drugs available for public use.
An agreement between the IPHA and the Department of Health on the provision of medicines lapsed at the end of February and discussions are under way on a new agreement.
(H)
Related Irish News Stories
Click here for the latest headlines.
12 November 2013
Gardai Appeal After Poison Stolen From Co Kildare Vet
Gardaí and the Irish Medicines Board (IMB) have appealed for anyone with any information about a robbery at a veterinary clinic in Celbridge, Co Kildare, to contact them.
Gardai Appeal After Poison Stolen From Co Kildare Vet
Gardaí and the Irish Medicines Board (IMB) have appealed for anyone with any information about a robbery at a veterinary clinic in Celbridge, Co Kildare, to contact them.
21 August 2012
IMB Warns Against Use Of Echinacea For Children
Parents should not give children under 12 any herbal products containing Echinacea, according to the Irish Medicines Board. The agency said there is no science to supporting the use of such products, and that there is also a risk of rare but severe side effects.
IMB Warns Against Use Of Echinacea For Children
Parents should not give children under 12 any herbal products containing Echinacea, according to the Irish Medicines Board. The agency said there is no science to supporting the use of such products, and that there is also a risk of rare but severe side effects.
01 December 2015
GE Healthcare To Create 140 New Jobs In Cork
GE Healthcare in Cork has announced it is to create 140 new jobs. The jobs are part of a $40 million investment in its manufacturing facility in Carrigtwohill. GE Healthcare is a subsidiary of the US multi-national General Electric.
GE Healthcare To Create 140 New Jobs In Cork
GE Healthcare in Cork has announced it is to create 140 new jobs. The jobs are part of a $40 million investment in its manufacturing facility in Carrigtwohill. GE Healthcare is a subsidiary of the US multi-national General Electric.
01 February 2010
Cost Of Medicines Falls 40%
The Irish pharmaceutical association has announced that with effect from today the cost of long established medicines will be reduced by 40%.
Cost Of Medicines Falls 40%
The Irish pharmaceutical association has announced that with effect from today the cost of long established medicines will be reduced by 40%.
15 October 2012
New Drug Price Deal Agreed
The pharmaceutical industry and the State have reached a new three-year agreement on drug prices, which is expected to yield savings of over €400m. The deal between the Irish Pharmaceutical Healthcare Association, the Department of Health and HSE will reduce State spending on medicines in various schemes.
New Drug Price Deal Agreed
The pharmaceutical industry and the State have reached a new three-year agreement on drug prices, which is expected to yield savings of over €400m. The deal between the Irish Pharmaceutical Healthcare Association, the Department of Health and HSE will reduce State spending on medicines in various schemes.
-
Ireland WeatherThis Evening and Tonight:It will be cloudy with a spell of heavy rain pushing south through late evening and the early hours, soon followed by some clear spells. Minimum temperature 6 °C.
